Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study. (4th July 2018)
- Record Type:
- Journal Article
- Title:
- Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study. (4th July 2018)
- Main Title:
- Proenkephalin and risk of developing chronic kidney disease: the Prevention of Renal and Vascular End-stage Disease study
- Authors:
- Kieneker, Lyanne M.
Hartmann, Oliver
Bergmann, Andreas
de Boer, Rudolf A.
Gansevoort, Ron T.
Joosten, Michel M.
Struck, Joachim
Bakker, Stephan J. L. - Abstract:
- Abstract: Background: Proenkephalin (pro-ENK) was recently found to be associated with low estimated glomerular filtration rate (eGFR). The association of pro-ENK with urinary albumin excretion (UAE), another marker for chronic kidney disease (CKD), has not been investigated. We examined the association of pro-ENK with eGFR and UAE as markers of CKD. Methods: We included 4375 subjects of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study. CKDeGFR was defined as development of eGFR <60 ml/min/1.73 m 2 and CKDUAE as albuminuria >30 mg/24 h. Results: Baseline median pro-ENK was 52.2 (IQR: 44.9–60.5) pmol/L. After a median follow-up of 8.4 (IQR: 7.9–8.9) years, 183 subjects developed CKDeGFR and 371 developed CKDUAE . The association of pro-ENK with CKDeGFR was modified by sex ( P interaction < 0.1), in such a way that after adjustment, the association only remained significant in men (adjusted hazard ratio per SD increase in 10 log-transformed pro-ENK, 1.65; 95% CI: 1.15–2.36) and not in women (0.83; 0.58–1.20). No significant association was observed between pro-ENK and CKDUAE risk (0.83; 0.58–1.20). Conclusions: High pro-ENK is associated with increased risk of CKDeGFR in men, but not in women. No association of pro-ENK with CKDUAE was observed. These results should be interpreted with caution, since residual confounding and potential overfitting of models could have influenced the results.
- Is Part Of:
- Biomarkers. Volume 23:Number 5(2018)
- Journal:
- Biomarkers
- Issue:
- Volume 23:Number 5(2018)
- Issue Display:
- Volume 23, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 23
- Issue:
- 5
- Issue Sort Value:
- 2018-0023-0005-0000
- Page Start:
- 474
- Page End:
- 482
- Publication Date:
- 2018-07-04
- Subjects:
- Biomarker -- chronic kidney disease -- epidemiology
Biochemical markers -- Periodicals
610.28 - Journal URLs:
- http://informahealthcare.com/journal/bmk ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/alphalist.html ↗ - DOI:
- 10.1080/1354750X.2018.1443514 ↗
- Languages:
- English
- ISSNs:
- 1354-750X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.704500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6756.xml